MedTrace Logo

Analysis of the Time Taken to Triple Therapy (NOVARTIS)

NCT01786720 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 20154

Last updated 2014-05-01

No results posted yet for this study

Summary

The proposed study will evaluate (for newly diagnosed Chronic Obstructive Pulmonary Disease (COPD) patients)the time taken to prescription of triple therapy by aiming to answer these following research questions:

1. The percentage of patients prescribed triple therapy, and when they first started receiving triple therapy.
2. For patients prescribed triple therapy, the time taken to triple therapy from initial diagnosis of COPD.
3. The variation in treatment pathways.
4. The factors associated with time taken to triple therapy.

Conditions

Sponsors & Collaborators

Principal Investigators

  • David Price, Prof, MD · University of Aberdeen

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01786720 on ClinicalTrials.gov